Carla Spazzolini

10PUBLICATIONS
118CO-AUTHORS
Molecular targetsHaematological tumoursExercise physiologyGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 22, 2026
Targeting trafficking defects in long QT syndrome type 2: a phase 2 clinical study with patient-specific cellular validation.

|May 13, 2026
MTMR4 variants have opposite gene-specific impact on life-threatening arrhythmic risk in type 1 and 2 long QT syndrome.

|Mar 18, 2026
CALM1, CALM2, and CALM3 expression and translation efficiency provide insight into the severity of calmodulinopathy.

Steffan Noe Niikanoff Christiansen, Stine Bøttcher Jacobsen, Jeppe Dyrberg Andersen

|Jul 15, 2025
TP-fusion at peak exercise: a novel marker for the recognition of unsuspected long QT syndrome patients.

Carlo Boeri, Patrizio Sarto, Paolo Cerea

|Sep 24, 2024
Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification.

Matthew J O'Neill, Chai-Ann Ng, Takanori Aizawa

|May 16, 2024
Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation.

Veronica Dusi, Federica Dagradi, Carla Spazzolini

Pageof 2

Frequent Collaborators

10 joint publications

Peter J Schwartz

8 joint publications

Lia Crotti

8 joint publications

Federica Dagradi

4 joint publications

Matteo Pedrazzini